GlaxoSmithKline: all 4,196 studies
Page 13 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old AdolescentsCompletedNCT01362322Phase 4Results posted
- An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung CancerCompletedNCT01362296Phase 2Results posted
- Mepolizumab in Nasal PolyposisCompletedNCT01362244Phase 2Results posted
- Infectious Pathogens in Acute Respiratory Illness in Adults and ElderlyCompletedNCT01360398Not applicableResults posted
- Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™CompletedNCT01358825Phase 4Results posted
- Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) VaccineCompletedNCT01357915Not applicableResults posted
- Pharmacokinetics/Pharmacodynamics of AlbiglutideCompletedNCT01357889Phase 2Results posted
- A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart FailureCompletedNCT01357850Phase 2Results posted
- Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) VaccineCompletedNCT01353703Phase 3Results posted
- Redirected Auto T Cells for Advanced MyelomaCompletedNCT01352286Phase 2Results posted
- Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination TherapyCompletedNCT01347060Results posted
- Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma PatientsCompletedNCT01346852Results posted
- Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1TerminatedNCT01345630Phase 3Results posted
- GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast AsiaCompletedNCT01345253Phase 3Results posted
- Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)CompletedNCT01345240Phase 3Results posted
- A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial SarcomaCompletedNCT01343043Phase 1Results posted
- Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529CompletedNCT01342952Phase 2Results posted
- Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular DegenerationCompletedNCT01342926Phase 2Results posted
- A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP))CompletedNCT01342913Phase 3Results posted
- Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and ToddlersCompletedNCT01340898Phase 3Results posted
- HIV Cohort Study At Johns Hopkins University, University of North Carolina at Chapel Hill and Vanderbilt UniversityCompletedNCT01339416Results posted
- Kaiser Permanente HIV Cohort StudyCompletedNCT01339403Results posted
- Paxil CR Bioequivalence Study Brazil - Fed AdministrationCompletedNCT01339247Phase 1Results posted
- Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety PopulationCompletedNCT01337336Results posted
- Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS)CompletedNCT01336621Phase 3Results posted
- A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPDCompletedNCT01336608Phase 3Results posted
- Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic HyperplasiaCompletedNCT01334723Results posted
- Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated ChildrenCompletedNCT01333813Phase 4Results posted
- A Comparison of Solid and Soluble Forms of Cold and Influenza RemediesCompletedNCT01332578Phase 4Results posted
- Treximet ™ Pharmacy Budget Impact Model Database Validation StudyCompletedNCT01332500Results posted
- Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic HyperplasiaCompletedNCT01332487Results posted
- Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance TherapiesCompletedNCT01332461Results posted
- Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor UseCompletedNCT01332435Results posted
- Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department VisitCompletedNCT01332357Results posted
- Efficacy and Safety of Ambrisentan in Children 8-18yrsTerminatedNCT01332331Phase 2Results posted
- Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic PatientsCompletedNCT01332292Phase 2Results posted
- Avandamet Bioequivalence Study Brazil - Fed AdministrationCompletedNCT01332071Phase 1Results posted
- Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01331694Results posted
- SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed AdminCompletedNCT01330303Phase 1Results posted
- HEPSERA Post Marketing SurveillanceCompletedNCT01329419Results posted
- Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care PopulationCompletedNCT01328964Results posted
- An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study ACompletedNCT01328444Phase 3Results posted
- A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc IntervalCompletedNCT01328054Phase 4Results posted
- A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.CompletedNCT01328041Phase 3Results posted
- A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis BCompletedNCT01327547Phase 4Results posted
- REQUIP RLS Post Marketing SurveillanceCompletedNCT01327339Results posted
- Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: MarketscanCompletedNCT01323998Results posted
- Consistency of Immunogenicity and Non Inferiority of GSK Biologicals' Candidate Malaria Vaccine Lots in ChildrenCompletedNCT01323972Phase 3Results posted
- Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted AdultsCompletedNCT01323959Phase 4Results posted
- Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in ChildrenCompletedNCT01323946Phase 2Results posted
- Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.CompletedNCT01323673Phase 4Results posted
- An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study BCompletedNCT01323660Phase 3Results posted
- Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated ToddlersCompletedNCT01323647Phase 3Results posted
- Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01323634Phase 3Results posted
- Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01323621Phase 3Results posted
- Study in Allergic Adults to Support the Development of Immunological AssaysCompletedNCT01320137Not applicableResults posted
- Open-Label Extension Study of GSK1605786ATerminatedNCT01318993Phase 3Results posted
- GSK1605786A in the Maintenance of Remission in Subjects With Crohn's DiseaseTerminatedNCT01316939Phase 3Results posted
- Paxil CR Bioequivalence Study BrazilCompletedNCT01316926Phase 1Results posted
- 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary DiseaseCompletedNCT01316913Phase 3Results posted
- 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary DiseaseCompletedNCT01316900Phase 3Results posted
- A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01316887Phase 3Results posted
- Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01313676Phase 3Results posted
- A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) PopulationTerminatedNCT01313663Phase 2Results posted
- A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPDCompletedNCT01313650Phase 3Results posted
- A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPDCompletedNCT01313637Phase 3Results posted
- Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of AgeCompletedNCT01310413Phase 3Results posted
- Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib VaccineCompletedNCT01309646Phase 3Results posted
- Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type IICompletedNCT01304238Results posted
- Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)CompletedNCT01300234Phase 3Results posted
- A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a PlaceboCompletedNCT01299610Phase 2Results posted
- ULTIVA Post Marketing SurveillanceCompletedNCT01299584Results posted
- AVODART(Dutasteride) Post-marketing Surveillance(PMS)CompletedNCT01299571Results posted
- Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy SubjectsCompletedNCT01295320Phase 2Results posted
- Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate EnlargementCompletedNCT01294592Phase 4Results posted
- An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010CompletedNCT01294553Results posted
- A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung FunctionCompletedNCT01287065Phase 2Results posted
- A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's DiseaseCompletedNCT01277666Phase 3Results posted
- Effect of Paracetamol on the Common ColdCompletedNCT01277081Phase 2Results posted
- Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years)CompletedNCT01277042Phase 3Results posted
- Combivir And Maraviroc In Antiretroviral Naive Subjects In RussiaCompletedNCT01275625Phase 4Results posted
- A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic RhinitisCompletedNCT01270958Phase 4Results posted
- Persistence and Booster Study of GSK Biologicals' Meningococcal Vaccine (GSK134612) in Healthy ChildrenCompletedNCT01266993Phase 3Results posted
- A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the BrainCompletedNCT01266967Phase 2Results posted
- A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)CompletedNCT01263015Phase 3Results posted
- SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast AdminCompletedNCT01262989Phase 1Results posted
- Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive AdultsCompletedNCT01262976Phase 2Results posted
- Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With GastroparesisCompletedNCT01262898Phase 2Results posted
- Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & InfantsCompletedNCT01262872Phase 2Results posted
- Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular CarcinomaCompletedNCT01258608Phase 1/2Results posted
- A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular DystrophyCompletedNCT01254019Phase 3Results posted
- Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to FoetusCompletedNCT01251744Not applicableResults posted
- The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 StudyCompletedNCT01249365Phase 3Results posted
- Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)CompletedNCT01248884Phase 2Results posted
- Efficacy of Alitretinoin Treatment in Patients With Pustular Form of PsoriasisCompletedNCT01245140Phase 2Results posted
- GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive MelanomaCompletedNCT01245062Phase 3Results posted
- Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old ChildrenCompletedNCT01245049Phase 3Results posted
- A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With AsthmaCompletedNCT01244984Phase 3Results posted
- Cancer in Patients With Gabapentin (GPRD)CompletedNCT01236053Results posted
- Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 YearsCompletedNCT01235975Phase 3Results posted